November 27, 2018 / 12:07 PM / 16 days ago

BRIEF-Roche Launches Assay To Be Used Across Multiple Tumor Types

Nov 27 (Reuters) - Roche Holding AG:

* ROCHE LAUNCHES FIRST IVD PAN-TRK IMMUNOHISTOCHEMISTRY ASSAY

* VENTANA PAN-TRK (EPR17341) ASSAY IS FIRST ASSAY OF ITS TYPE TO DETECT TROPOMYOSIN RECEPTOR KINASE (TRK) WITH ANTICIPATED USE ACROSS MULTIPLE SOLID TUMOR TYPES

* ASSAY IS EXPECTED TO PROVIDE IMPROVED DATA ON PREVALENCE OF TRK PROTEINS IN TUMOR TISSUE STUDIES

* SIGNIFICANCE OF TRK FUSION PROTEINS IS CURRENTLY BEING INVESTIGATED IN VARIOUS CANCER INDICATIONS Source text for Eikon: Further company coverage: (Reporting by Berlin Speed Desk)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below